Please login to the form below

Not currently logged in
Email:
Password:

M3 appoints Paul Rice as chief operating officer

Simon Walker also joins the online doctor communities group

Paul RiceM3 has appointed Paul Rice as chief operating officer for its European operations, a role that will see him focus on further developing M3’s services.

Rice joins the online doctor communities group from UK-based clinical trials logistics firm Marken, where he served as its EMEA general manager for nearly three years.

Prior to that Rice, who has over 25 years of industry experience, spent time as European commercial affairs director for Walgreens Boots and at Merck & Co as its EMEA executive director of distribution operations, commercial and supply chain.

Dr Tim Ringrose, CEO of M3 EU, said: “M3’s capabilities are becoming firmly established in key European markets and I’m delighted to welcome Paul to M3 as we continue to drive M3’s growth in key markets and expand the services we provide to healthcare.”

The company has also appointed Simon Walker as a business director working across its portfolio of promotional and medical education solutions on a global basis.

Walker has over 20 years experience with the BMJ (British Medical Journal) and has also worked with organisations such as Kanga Healthcare and RCNi.

31st May 2017

From: Marketing

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
M3 (EU)

M3 has over 20 years’ experience in building online doctor communities. M3 is the world’s largest network of verified doctors...

Latest intelligence

When is an agency not an agency?
The PR Week UK Top 150 Consultancies prompts anticipation and curiosity. But can a virtual collective of freelancers fairly be compared and ranked against conventional agencies?...
Why big pharma needs to be braver
The last few years have seen the pharmaceutical industry undergo a rapid metamorphosis in the face of unprecedented change, but communications are one area that still needs an injection of...
Leveraging Real-World Evidence for Cell and Gene Therapies
Regulators and reimbursement bodies are increasingly turning to real-world evidence (RWE) to understand the long-term value of drugs, in particular novel therapies. Here, Mariam Bibi, Senior Director, Global RWE at...